FDA Clears Ready-to-Use Flow Cytometry Tests for Leukemia and Lymphoma
The FDA clearances cover two tests for the identification and diagnosis of B-cell non-Hodgkin lymphoma, including chronic lymphocytic leukemia.
The FDA clearances cover two tests for the identification and diagnosis of B-cell non-Hodgkin lymphoma, including chronic lymphocytic leukemia.
A new test for Roche received FDA clearance as a sensitive diagnostic tool to differentiate B-cell lymphomas for improved diagnosis.
Genomic Testing Cooperative will present data on the use of their machine learning solution that reflects its innovation strategy in improving cancer care.
AI-driven digital pathology can accelerate cancer diagnosis and clinical trial recruitment.
Read MoreThe automated PS-10 sample preparation system streamlines workflows and standardizes clinical flow cytometry testing.
Read MoreThe Aurora system is now available with five lasers, making it possible for researchers to visualize more than 30 colors from a single sample.
Read MoreThe biomarker may provide a cost-effective and efficient means to identify elevated ROS1 protein expression in cancer.
Read MoreIn a field where highly trained professionals interact on a daily basis with an ever-changing array of innovative technologies, new and useful ideas seem to be around every corner.
Read MoreNew 10-color system with Kaluza C software streamlines workflow and QC reporting for flow cytometry in leukemia and lymphoma analysis.
Read MoreNano-Signature Discovery Could Revolutionize Cancer Diagnosis A quick and easy test to...
Read MoreContinued validation of Lophius’ development capabilities bodes well as the company advances into tuberculosis diagnostics as its next focus area.
Read MoreThe new technology has proved to be up to 90% accurate in tests involving 200 human cancer samples and normal DNA.
Read MoreDroplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.
Read MoreMultidisciplinary guidance document focuses on specimen requirements for the diagnosis of lymphoma.
Read MoreThis month’s Product Spotlight features new products from such companies as Advanced Instruments, Beckman Coulter, and Thermo Fisher Scientific.
Read MoreHTG’s next-generation sequencing assay enables subtyping of DLBCL as activated B-cell-like or germinal center B-cell-like.
Read MoreUnder a new grant from the National Cancer Institute, Advanced Cell Diagnostics will partner with the Cleveland Clinic to develop an ultrasensitive diagnostic test for B-cell lymphoma.
Read MoreA new collaboration plans to provide genomic profiling and information for patients that have been unsuccessful on repeated therapy for the group of cancers that include leukemias, lymphomas, and myeloproliferative and myelodysplastic diseases.
Read More